We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC: Authorized Generics Don’t Dent Patent Challenges
Brand drugmakers’ introduction of authorized generics (AG) has little effect on generic-drug makers’ attempts to challenge patents, an FTC report finds.